U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07847983) titled 'Heart Failure in Women: Epidemiological and Prognostic Insights' on Sept. 22.
Brief Summary: Heart failure (HF) is a leading cause of hospital admission in older adults and women account for more than half of these admissions, yet they remain under-represented in prospective HF cohorts. Exposures specific to women, such as complications of pregnancy and the timing of menopause, are seldom recorded in HF registries, and treatment is usually described by drug class rather than by the dose actually achieved.
HER-HF is a national, prospective, multicentre observational cohort study that enrols women aged 18 years or older admitted to ...